On June 24, Axinn partners Jonathan Harris and Jason Murata will speak at the American Conference Institute’s 10th Annual Summit on Biosimilars Conference in New York. Jonathan will participate in the panel entitled, "Challenging Patents on Reference Drugs at the PTAB in the Age of Reform." Jason will participate in the panel entitled, "A Question of Standing: Establishing the Right to Appeal a PTAB Decision."
This two-day event will promote the discussion of the future of biosimilars and formulate solutions to the complex regulatory and patent challenges ahead with industry leaders from both innovator and biosimilar companies.
Click here for more information.